Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.

Kadatz M, Gill JS, Gill J, Formica RN, Klarenbach S.

J Am Soc Nephrol. 2019 Nov 8. pii: ASN.2019070646. doi: 10.1681/ASN.2019070646. [Epub ahead of print]

PMID:
31704739
2.

Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy.

Gill JS, Formica RN, Levitsky J.

J Am Soc Nephrol. 2019 Oct;30(10):1778-1780. doi: 10.1681/ASN.2019070726. Epub 2019 Sep 12. No abstract available.

PMID:
31570540
3.

ESKD Risk in Living Kidney Donors "Like Me".

Newell KA, Formica RN.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):970-971. doi: 10.2215/CJN.06010519. Epub 2019 Jun 25. No abstract available.

PMID:
31278113
4.

And equal access for all? The future of deceased donor kidney allocation.

Formica RN.

Am J Transplant. 2018 Aug;18(8):1837-1838. doi: 10.1111/ajt.14964. Epub 2018 Jul 10. No abstract available.

5.

Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipients.

Liapakis A, Formica RN, Levitsky J.

Curr Opin Organ Transplant. 2018 Apr;23(2):257-263. doi: 10.1097/MOT.0000000000000504. Review.

PMID:
29432255
6.

The role of the kidney in combined liver-kidney transplantation.

Formica RN Jr.

Liver Transpl. 2018 Feb;24(2):164-165. doi: 10.1002/lt.24995. No abstract available.

7.

Perspectives on the Strengths and Weaknesses of the National Kidney Allocation System.

Formica RN Jr.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2056. doi: 10.2215/CJN.08640817. Epub 2017 Nov 21. No abstract available.

8.

Being Thoughtful about Desensitization.

Formica RN Jr, Kulkarni S.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1878-1880. doi: 10.2215/CJN.09000817. Epub 2017 Oct 3. No abstract available.

9.

Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?

Levitsky J, Formica RN.

Am J Transplant. 2017 Nov;17(11):2988. doi: 10.1111/ajt.14478. Epub 2017 Sep 23. No abstract available.

10.

The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.

Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M.

Am J Transplant. 2017 Nov;17(11):2790-2802. doi: 10.1111/ajt.14381. Epub 2017 Jul 1.

11.

Opportunities to Increase Availability of Deceased Donor Kidneys.

Formica RN Jr.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):871-873. doi: 10.2215/CJN.04490417. Epub 2017 May 25. No abstract available.

12.

Changes in united network for organ sharing policy for simultaneous liver-kidney allocation.

Merola J, Formica RN, Mulligan DC.

Clin Liver Dis (Hoboken). 2017 Feb 3;9(1):21-24. doi: 10.1002/cld.609. eCollection 2017 Jan. Review. No abstract available.

13.

Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.

Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A.

Am J Transplant. 2017 Apr;17(4):901-911. doi: 10.1111/ajt.14173. Epub 2017 Feb 2.

14.

A critical assessment on kidney allocation systems.

Formica RN Jr.

Transplant Rev (Orlando). 2017 Jan;31(1):61-67. doi: 10.1016/j.trre.2016.10.002. Epub 2016 Oct 8. Review.

PMID:
27919635
15.

Simultaneous liver kidney transplantation.

Formica RN Jr.

Curr Opin Nephrol Hypertens. 2016 Nov;25(6):577-582. Review.

PMID:
27653420
16.

Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial.

Kulkarni S, Kirkiles-Smith NC, Deng YH, Formica RN, Moeckel G, Broecker V, Bow L, Tomlin R, Pober JS.

Am J Transplant. 2017 Mar;17(3):682-691. doi: 10.1111/ajt.14001. Epub 2016 Sep 16.

17.

The Long-Term Follow-up and Support for Living Organ Donors: A Center-Based Initiative Founded on Developing a Community of Living Donors.

Kulkarni S, Thiessen C, Formica RN, Schilsky M, Mulligan D, D'Aquila R.

Am J Transplant. 2016 Dec;16(12):3385-3391. doi: 10.1111/ajt.14005. Epub 2016 Sep 14.

18.

Utility of Applying Quality Assessment Tools for Kidneys With KDPI ≥80.

Doshi MD, Reese PP, Hall IE, Schröppel B, Ficek J, Formica RN, Weng FL, Hasz RD, Thiessen-Philbrook H, Parikh CR.

Transplantation. 2017 Jun;101(6):1125-1133. doi: 10.1097/TP.0000000000001388.

19.

Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation.

Azar MM, Malinis MF, Moss J, Formica RN, Villanueva MS.

Int J STD AIDS. 2017 Apr;28(5):447-458. doi: 10.1177/0956462416651528. Epub 2016 Jul 10.

PMID:
27193421
20.

Simultaneous Liver-Kidney Allocation: Let's Not Make Perfect the Enemy of Good.

Formica RN Jr.

Am J Transplant. 2016 Sep;16(9):2765. doi: 10.1111/ajt.13873. Epub 2016 Jul 13. No abstract available.

21.

Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation.

Stewart DE, Kucheryavaya AY, Klassen DK, Turgeon NA, Formica RN, Aeder MI.

Am J Transplant. 2016 Jun;16(6):1834-47. doi: 10.1111/ajt.13770. Epub 2016 Mar 31.

22.

What Is the Price of Altruism?

Formica RN Jr, Newell KA.

Am J Transplant. 2016 Mar;16(3):741-2. doi: 10.1111/ajt.13590. Epub 2016 Feb 4. No abstract available.

23.

Allocating Deceased Donor Kidneys to Sensitized Candidates.

Formica RN Jr.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):377-8. doi: 10.2215/CJN.13641215. Epub 2016 Feb 2. No abstract available.

24.

Duration of prophylaxis against fungal infection in kidney transplant recipients.

Guerra CM, Formica RN, Kulkarni S, Asch WS, Tichy EM.

Prog Transplant. 2015 Dec;25(4):311-5. doi: 10.7182/pit2015929.

PMID:
26645924
25.

Engaging Living Kidney Donors in a New Paradigm of Postdonation Care.

Newell KA, Formica RN, Gill JS.

Am J Transplant. 2016 Jan;16(1):29-32. doi: 10.1111/ajt.13524. Epub 2015 Dec 7.

26.

Simultaneous Liver-Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources.

Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, Mulligan D.

Am J Transplant. 2016 Mar;16(3):758-66. doi: 10.1111/ajt.13631. Epub 2016 Jan 30.

27.

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.

Hricik DE, Augustine J, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Spain K, Iklé D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2015 Dec;15(12):3166-73. doi: 10.1111/ajt.13401. Epub 2015 Jul 30.

28.

Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant Outcomes.

Butala NM, King MD, Reitsma W, Formica RN, Abt PL, Reese PP, Parikh CR.

Transplantation. 2015 Dec;99(12):2617-24. doi: 10.1097/TP.0000000000000773.

29.

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS; Clinical Trials in Organ Transplantation-09 Consortium.

J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29.

30.

Whose kidney is it anyway? The complexities of sharing deceased donor kidneys.

Andreoni KA, Formica RN Jr.

Am J Transplant. 2014 Oct;14(10):2204-5. doi: 10.1111/ajt.12865. Epub 2014 Sep 12. No abstract available.

31.

New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.

Israni AK, Salkowski N, Gustafson S, Snyder JJ, Friedewald JJ, Formica RN, Wang X, Shteyn E, Cherikh W, Stewart D, Samana CJ, Chung A, Hart A, Kasiske BL.

J Am Soc Nephrol. 2014 Aug;25(8):1842-8. doi: 10.1681/ASN.2013070784. Epub 2014 May 15.

32.

Cytomegalovirus glomerulopathy and cytomegalovirus interstitial nephritis on sequential transplant kidney biopsies.

Vichot AA, Formica RN Jr, Moeckel GW.

Am J Kidney Dis. 2014 Mar;63(3):536-9. doi: 10.1053/j.ajkd.2013.08.021. Epub 2013 Oct 25.

PMID:
24568687
33.

The kidney allocation system.

Friedewald JJ, Samana CJ, Kasiske BL, Israni AK, Stewart D, Cherikh W, Formica RN.

Surg Clin North Am. 2013 Dec;93(6):1395-406. doi: 10.1016/j.suc.2013.08.007.

PMID:
24206858
34.

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M, Spain K, Ikle D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2013 Oct;13(10):2634-44. doi: 10.1111/ajt.12426. Epub 2013 Aug 22.

35.

Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.

Heavner MS, Tichy EM, Yazdi M, Formica RN Jr, Kulkarni S, Emre S.

Am J Health Syst Pharm. 2013 Sep 1;70(17):1507-12. doi: 10.2146/ajhp120783.

PMID:
23943182
36.

A renal variant of Fabry disease: A case with a novel Gal A hemizygote mutation.

H Mukdsi J, Gutiérrez S, Barrón B, Novoa P, Fernández S, de Diller AB, I Torres A, Formica RN Jr, Orías M.

J Nephropathol. 2012 Oct;1(3):194-7. doi: 10.5812/nephropathol.8123. Epub 2012 Oct 1.

37.

A one-day centralized work-up for kidney transplant recipient candidates: a quality improvement report.

Formica RN Jr, Barrantes F, Asch WS, Bia MJ, Coca S, Kalyesubula R, McCloskey B, Leary T, Arvelakis A, Kulkarni S.

Am J Kidney Dis. 2012 Aug;60(2):288-94. doi: 10.1053/j.ajkd.2012.04.008. Epub 2012 May 8.

PMID:
22571868
38.

An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.

Nelson WK, Formica RN Jr, Cooper DL, Schwartz PE, Rutherford TJ.

J Oncol Pharm Pract. 2012 Sep;18(3):323-32. doi: 10.1177/1078155211435714. Epub 2012 Feb 13.

PMID:
22331238
39.

When and how should immunosuppression be tapered for the failed renal allograft?

Formica RN Jr.

Semin Dial. 2011 Jul-Aug;24(4):371-3. doi: 10.1111/j.1525-139X.2011.00900.x. Epub 2011 Jul 29. No abstract available.

PMID:
21801218
40.

Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework.

Licurse A, Kim MC, Dziura J, Forman HP, Formica RN, Makarov DV, Parikh CR, Gross CP.

Arch Intern Med. 2010 Nov 22;170(21):1900-7. doi: 10.1001/archinternmed.2010.419.

PMID:
21098348
41.

Significant sirolimus and dronedarone interaction in a kidney transplant recipient.

Tichy EM, Medwid AJ, Mills EA, Formica RN, Kulkarni S.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1338-41. doi: 10.1345/aph.1P114. Epub 2010 May 18.

PMID:
20484171
42.

Kidney transplantation and HIV: does recipient privacy outweigh the donor's right to information?

Formica RN Jr, Asch WS, Wagner KR, Kulkarni S.

Clin J Am Soc Nephrol. 2010 May;5(5):924-8. doi: 10.2215/CJN.06820909. Epub 2010 Mar 4.

43.

Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis.

Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR.

Nephrol Dial Transplant. 2009 Mar;24(3):1039-47. doi: 10.1093/ndt/gfn667. Epub 2008 Dec 22. Review.

PMID:
19103734
44.

Medication errors in the outpatient setting: classification and root cause analysis.

Friedman AL, Geoghegan SR, Sowers NM, Kulkarni S, Formica RN Jr.

Arch Surg. 2007 Mar;142(3):278-83; discussion 284.

PMID:
17372053
45.

A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.

Formica RN Jr, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ.

Nephrol Dial Transplant. 2006 May;21(5):1389-94. Epub 2006 Jan 23.

PMID:
16431893
46.
47.

The evolving experience using everolimus in clinical transplantation.

Formica RN Jr, Lorber KM, Friedman AL, Bia MJ, Lakkis F, Smith JD, Lorber MI.

Transplant Proc. 2004 Mar;36(2 Suppl):495S-499S. Review.

PMID:
15041395
48.

Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation.

Formica RN Jr, Lorber KM, Friedman AL, Bia MJ, Lakkis F, Smith JD, Lorber MI.

Transplant Proc. 2003 May;35(3 Suppl):95S-98S.

PMID:
12742475
49.

Prenatal protein malnutrition alters response to reward in adult rats.

Tonkiss J, Shukitt-Hale B, Formica RN, Rocco FJ, Galler JR.

Physiol Behav. 1990 Nov;48(5):675-80.

PMID:
2127961
50.

Fetal protein malnutrition impairs acquisition of a DRL task in adult rats.

Tonkiss J, Galler JR, Formica RN, Shukitt-Hale B, Timm RR.

Physiol Behav. 1990 Jul;48(1):73-7.

PMID:
2122484

Supplemental Content

Loading ...
Support Center